Elanco: Past, Present and Future
Since our start, Elanco has worked to empower veterinarians, farmers, and all those caring for animals with the tools needed to help animals live healthy lives.
A Legacy of Innovation
For more than 65 years, we've focused on delivering innovative animal health solutions that solve our customers’ greatest challenges.
1950-1989
Where it All Began
Elanco has helped shape the lives of animals and their care providers for more than half a century.
1953
The Beginning of Elanco Animal Health
Eli Lilly and Company introduces the first antibiotic exclusively for veterinary use.
1960
Growing Rapidly
In 1960, Elanco began growing rapidly into new countries and markets.
1990-2000
2000-2010
2007
Bringing Employees Together
Elanco builds a dedicated global headquarters campus in Greenfield, Ind., bringing together employees from all areas of the company for the first time.
2007
Growing Through Acquisition
Elanco launches Companion Animal parasiticides and acquires long-term partner Ivy Animal Health and launches its Pet Animal businesses.
2007
Elanco adds Monsanto Dairy Business
2020
Elanco Closes Acquisition of Bayer Animal Health
Elanco, now with the addition of Bayer Animal Health, has improved capabilities, scale and global reach to position the company as a long-term leader in the growing global animal health market.
2010
European Expansion
Expands European business: Pfizer vaccines
2011
Elanco acquires Janssen Animal Health.
2012
A Growing Portfolio
With the acquisition of ChemGen, Elanco obtains a portfolio of feed enzyme products for poultry, egg and meat production.
2013
Global Growth and Product Expansion
Elanco's Pet portfolio grows and en
Elanco Foundation
Elanco establishes the Elanco Foundation, which is the first-ever charitable foundation in animal health.
Elanco Completes Separation from Lilly
Elanco becomes a fully-independent pure play animal health company
2021 to date
2021
ESG Summary Report
Elanco releases its first independent ESG Summary Report
Building a healthy enterprise and driving sustainability are essential to our success and leadership in animal health.
— Todd Young, executive vice president and CFO
Elanco closes acquisition of Kindred Biosciences
The transaction advances Elanco’s access to the fast-growing $1+ billion dermatology market, complementing the company’s existing pipeline and increasing R&D capability in biologics and monoclonal antibodies.
Animals are the Answer
Sustainable Solutions for Zero Hunger by 2030: A Vision for Animal Agriculture Forum to explore solutions to combat climate change while keeping the world nourished.
Elanco Selected for 2021 FORTUNE’s Change the World List
FORTUNE's list recognizes companies that have made an important social or environmental impact through their profit-making strategy and operations.
2022
MAHABA (Managing Animal Health and Acaricides for a Better Africa)
Elanco Expands Commitment to Creating Shared Value, Launches New Initiative Empowering Small-Scale Producers in Sub-Saharan Africa
Elanco and Ginkgo Bioworks Launch BiomEdit
A new Animal Health Company Leveraging Microbiome Technology
Elanco Breaks Ground on new Headquarters
Elanco Breaks Ground on State-of-the-Art Campus, Creating Indianapolis’ Newest Landmark
You Might Be Interested in...
Get to know Elanco and our perspective on animal health by exploring more articles below.
Purpose-Driven Culture
Learn how we foster a culture that's driven by values and celebrates our company purpose.
Our People
Read about the individuals who shape Elanco and bring our culture and values to life.
Our Initiatives
See how we advance our vision of Food and Companionship Enriching Life through participation in programs and community projects.
What's Happening
Join Elanco
Investor Relations
About Elanco
Learn why we're a leading provider of innovative solutions that protect and enhance animal health.
Elanco's Healthy Purpose, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. © 2023 Elanco or its affiliates.
EM-BE-23-0179